{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:28:22Z","timestamp":1762298902525,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UH3DA041146"],"award-info":[{"award-number":["UH3DA041146"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bmc.2018.11.027","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T12:34:06Z","timestamp":1542717246000},"page":"125-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Heat shock proteins: A dual carrier-adjuvant for an anti-drug vaccine against heroin"],"prefix":"10.1016","volume":"27","author":[{"given":"Candy S.","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2826-4078","authenticated-orcid":false,"given":"Beverly","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim D.","family":"Janda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2018.11.027_b0005","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.7b03334","article-title":"Development of a clinically-viable heroin vaccine","author":"Bremer","year":"2017","journal-title":"J Am Chem Soc"},{"issue":"3","key":"10.1016\/j.bmc.2018.11.027_b0010","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1021\/acs.molpharmaceut.7b00933","article-title":"Enhancing efficacy and stability of an antiheroin vaccine: examination of antinociception, opioid binding profile, and lethality","volume":"15","author":"Hwang","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmc.2018.11.027_b0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/SAR.S24800","article-title":"Problematic use of prescription-type opioids prior to heroin use among young heroin injectors","volume":"2","author":"Pollini","year":"2011","journal-title":"Substance Abuse Rehabil"},{"key":"10.1016\/j.bmc.2018.11.027_b0020","unstructured":"Principles of Drug Addiction Treatment: A Research-Based Guide, Third Edition. NIH National Institute on Drug Abuse; U.S. Department of Health and Human Services 2012."},{"issue":"22","key":"10.1016\/j.bmc.2018.11.027_b0025","doi-asserted-by":"crossref","first-page":"9036","DOI":"10.1073\/pnas.1219159110","article-title":"Dynamic vaccine blocks relapse to compulsive intake of heroin","volume":"110","author":"Schlosburg","year":"2013","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.bmc.2018.11.027_b0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/acs.jmedchem.7b01427","article-title":"A stable heroin analogue that can serve as a vaccine hapten to induce antibodies that block the effects of heroin and its metabolites in rodents and that cross-react immunologically with related drugs of abuse","volume":"61","author":"Sulima","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.11.027_b0035","article-title":"An advance in prescription opioid vaccines: overdose mortality reduction and extraordinary alteration of drug half-life","author":"Kimishima","year":"2016","journal-title":"ACS Chem Biol"},{"issue":"11","key":"10.1016\/j.bmc.2018.11.027_b0040","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/anie.201511654","article-title":"Combatting synthetic designer opioids: a conjugate vaccine ablates lethal doses of fentanyl class drugs","volume":"55","author":"Bremer","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7","key":"10.1016\/j.bmc.2018.11.027_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101807","article-title":"Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats","volume":"9","author":"Pravetoni","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2018.11.027_b0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/bs.irn.2016.02.009","article-title":"Animal models and the development of vaccines to treat substance use disorders","volume":"126","author":"Ohia-Nwoko","year":"2016","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.bmc.2018.11.027_b0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2014.04.003","article-title":"Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial","volume":"140","author":"Kosten","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"10.1016\/j.bmc.2018.11.027_b0060","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/add.12573","article-title":"Efficacy of the nicotine vaccine 3\u2032-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial","volume":"109","author":"Hoogsteder","year":"2014","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.bmc.2018.11.027_b0065","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1021\/mp500520r","article-title":"Flagellin as carrier and adjuvant in cocaine vaccine development","volume":"12","author":"Lockner","year":"2015","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.bmc.2018.11.027_b0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1586\/erv.13.1","article-title":"Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse","volume":"12","author":"Brimijoin","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.bmc.2018.11.027_b0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1586\/14760584.7.3.383","article-title":"Heat-shock protein-based vaccines for cancer and infectious disease","volume":"7","author":"Binder","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.bmc.2018.11.027_b0080","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2567.2007.02564.x","article-title":"Mycobacterium tuberculosis heat-shock protein 70 impairs maturation of dendritic cells from bone marrow precursors, induces interleukin-10 production and inhibits T-cell proliferation in vitro","volume":"121","author":"Motta","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.bmc.2018.11.027_b0085","series-title":"Stress-Inducible Cellular Responses","first-page":"451","article-title":"Heat shock proteins as immunological carriers and vaccines","author":"Suzue","year":"1996"},{"issue":"15","key":"10.1016\/j.bmc.2018.11.027_b0090","doi-asserted-by":"crossref","first-page":"12387","DOI":"10.1074\/jbc.M111.307579","article-title":"Inducible heat shock protein 70 reduces T cell responses and stimulatory capacity of monocyte-derived dendritic cells","volume":"287","author":"Stocki","year":"2012","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.bmc.2018.11.027_b0095","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1189\/jlb.0410236","article-title":"Heat shock proteins: darwinistic immune modulation on dangerous grounds","volume":"88","author":"van Wijk","year":"2010","journal-title":"J Leukoc Biol"},{"issue":"43","key":"10.1016\/j.bmc.2018.11.027_b0100","doi-asserted-by":"crossref","first-page":"31688","DOI":"10.1074\/jbc.M704129200","article-title":"Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling","volume":"282","author":"Bendz","year":"2007","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.bmc.2018.11.027_b0105","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1002\/eji.200535050","article-title":"The heat shock protein Hsp70 enhances antigen-specific proliferation of human CD4+ memory T cells","volume":"35","author":"Haug","year":"2005","journal-title":"Eur J Immunol"},{"issue":"Suppl_5","key":"10.1016\/j.bmc.2018.11.027_b0110","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1093\/clinids\/9.Supplement_5.S512","article-title":"Characterization of a nontoxic monophosphoryl lipid A","volume":"9","author":"Johnson","year":"1987","journal-title":"Rev Infect Dis"},{"issue":"31","key":"10.1016\/j.bmc.2018.11.027_b0115","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1039\/C4CC00682H","article-title":"Lipid tucaresol as an adjuvant for methamphetamine vaccine development","volume":"50","author":"Collins","year":"2014","journal-title":"Chem Commun (Camb)"},{"issue":"2","key":"10.1016\/j.bmc.2018.11.027_b0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2958.1989.tb01801.x","article-title":"Biochemical and antigenic characterization of the Mycobacterium tuberculosis 71 kD antigen, a member of the 70 kD heat-shock protein family","volume":"3","author":"Mehlert","year":"1989","journal-title":"Mol Microbiol"},{"issue":"5","key":"10.1016\/j.bmc.2018.11.027_b0125","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1021\/mp1001069","article-title":"Enhanced generation of cytotoxic T lymphocytes by heat shock protein 70 fusion proteins harboring both CD8+ T Cell and CD4+ T cell epitopes","volume":"7","author":"Takemoto","year":"2010","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.bmc.2018.11.027_b0130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.chembiol.2015.02.004","article-title":"A small molecule inhibitor of atpase activity of Hsp70 induces apoptosis and has antitumor activities","volume":"22","author":"Ko","year":"2015","journal-title":"Chem Biol"},{"issue":"3","key":"10.1016\/j.bmc.2018.11.027_b0135","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/mp400631w","article-title":"Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacy","volume":"11","author":"Bremer","year":"2014","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1016\/j.bmc.2018.11.027_b0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jat\/33.7.345","article-title":"Determination of heroin and its main metabolites in small sample volumes of whole blood and brain tissue by reversed-phase liquid chromatography-tandem mass spectrometry","volume":"33","author":"Karinen","year":"2009","journal-title":"J Anal Toxicol"},{"issue":"26","key":"10.1016\/j.bmc.2018.11.027_b0145","doi-asserted-by":"crossref","first-page":"15253","DOI":"10.1073\/pnas.95.26.15253","article-title":"The biochemical properties of the ATPase activity of a 70-kDa heat shock protein (Hsp70) are governed by the C-terminal domains","volume":"95","author":"Lopez-Buesa","year":"1998","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.bmc.2018.11.027_b0150","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1096\/fj.11-184556","article-title":"Antigen depot is not required for alum adjuvanticity","volume":"26","author":"Hutchison","year":"2012","journal-title":"FASEB J"},{"issue":"14","key":"10.1016\/j.bmc.2018.11.027_b0155","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/jm200461m","article-title":"A vaccine strategy that induces protective immunity against heroin","volume":"54","author":"Stowe","year":"2011","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.bmc.2018.11.027_b0160","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1021\/bc300611b","article-title":"Synergistic stimulation of antigen presenting cells via TLR by combining CpG ODN and poly(gamma-glutamic acid)-based nanoparticles as vaccine adjuvants","volume":"24","author":"Shima","year":"2013","journal-title":"Bioconjug Chem"},{"issue":"3","key":"10.1016\/j.bmc.2018.11.027_b0165","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cmdc.201200487","article-title":"Modern subunit vaccines: development, components, and research opportunities","volume":"8","author":"Moyle","year":"2013","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.bmc.2018.11.027_b0170","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2249.1994.tb06130.x","article-title":"Heat shock proteins as carrier molecules: in vivo helper effect mediated by Escherichia coli GroEL and DnaK proteins requires cross-linking with antigen","volume":"98","author":"Barrios","year":"1994","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.bmc.2018.11.027_b0175","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.4049\/jimmunol.173.8.5130","article-title":"Bacterial Heat Shock Proteins Enhance Class II MHC Antigen Processing and Presentation of Chaperoned Peptides to CD4<sup>+<\/sup> T Cells","volume":"173","author":"Tobian","year":"2004","journal-title":"J Immunol"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089618317140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089618317140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:01:13Z","timestamp":1760835673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089618317140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0968089618317140"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2018.11.027","relation":{},"ISSN":["0968-0896"],"issn-type":[{"type":"print","value":"0968-0896"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heat shock proteins: A dual carrier-adjuvant for an anti-drug vaccine against heroin","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2018.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}